Vascular brachytherapy in renal artery restenosis

Current Opinion in Cardiology

Volumn 19, Issue 4, 2004, Pages 332-335

  Reilly, John P ^a   Ramee, Steven R ^a  

^a OCHSNER CLINIC FOUNDATION   (United States)

Author keywords

Brachytherapy; Hypertension; Renal artery stenosis; Restenosis; Stents

Indexed keywords

ADVENTITIA; BETA RADIATION; BLOOD VESSEL CALCIFICATION; BLOOD VESSEL DIAMETER; BLOOD VESSEL INJURY; BRACHYTHERAPY; CELL PROLIFERATION; DNA STRAND BREAKAGE; EPITHELIUM HYPERPLASIA; GAMMA RADIATION; HUMAN; IONIZING RADIATION; KIDNEY ARTERY STENOSIS; MITOSIS; MYOFIBROBLAST; PHOTON; PRIORITY JOURNAL; RADIATION DOSE; RECURRENT DISEASE; RESTENOSIS; REVIEW; RISK FACTOR; STENT; TARGET CELL; VASOCONSTRICTION;

BRACHYTHERAPY; HUMANS; RECURRENCE; RENAL ARTERY OBSTRUCTION; TREATMENT OUTCOME;

EID: 3142715281     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hco.0000127137.58602.2f     Document Type: Review

References (50)

1. Lederman RJ, Mendelsohn FO, Santos R, et al.: Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001, 142:314-323.
2. Moussavian M, Casterella PJ, Teirstein PS: Restenosis after angioplasty. Curr Treat Options Cardiovasc Med 2001, 3:103-113.
3. Teirstein PS: Living the dream of no restenosis. Circulation 2001, 104:1996-1998.
4. Post MJ, de Smet BJ, van der Helm Y, et al.: Arterial remodeling after balloon angioplasty or stenting in an atherosclerotic experimental model. Circulation 1997, 96:996-1003.
5. de Smet BJ, Kuntz RE, van der Helm YJ, et al.: Relationship between plaque mass and neointimal hyperplasia after stent placement in Yucatan micropigs. Radiology 1997, 203:484-488.
6. Haude M, Erbel R, Issa H, Meyer J: Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents. J Am Coll Cardiol 1993, 21:26-34.
7. Hanke H, Kamenz J, Hassenstein S, et al.: Prolonged proliferative response of smooth muscle cells after experimental intravascular stenting. Eur Heart J 1995, 16:785-793.
8. Reidy MA, Fingerle J, Lindner V: Factors controlling the development of arterial lesions after injury. Circulation 1992, 86:III43-III46.
9. Wilcox JN, Okamoto El, Nakahara KI, et al.: Perivascular responses after angioplasty which may contribute to postangioplasty restenosis: a role for circulating myofibroblast precursors? Ann N Y Acad Sci 2001, 947:68-90; discussion 90-92.
10. Hojo Y, Ikeda U, Katsuki T, et al.: Chemokine expression in coronary circulation after coronary angioplasty as a prognostic factor for restenosis. Atherosclerosis 2001, 156:165-170.
11. Schatz RA, Palmaz JC, Tio FO, et al.: Balloon-expandable intracoronary stents in the adult dog. Circulation 1987, 76:450-457.
12. Schwartz RS, Huber KC, Murphy JG, et al.: Restenosis and the proportional neointimal response to coronary artery injury: results in a porcine model. J Am Coll Cardiol 1992, 19:267-274.
13. Mudra H, Blasini R, Regar E, et al.: Intravascular ultrasound assessment of the balloon-expandable Palmaz-Schab coronary stent. Coron Artery Dis 1993, 4:791-799.
14. Leon MB, Teirstein PS, Moses JW, et al.: Localized intracoronary gamma-radiation therapy to inhibit the recurrence of restenosis after stenting. N Engl J Med 2001, 344:250-256.
15. Suntharalingam M, Laskey W, Lansky AJ, et al.: Clinical and angiographic outcomes after use of 90Strontium/90Yttrium beta radiation for the treatment of in-stent restenosis: results from the Stents and Radiation Therapy 40 (START 40) registry. Int J Radiat Oncol Biol Phys 2002, 52:1075-1082.
16. Waksman R, Raizner AE, Yeung AC, et al.: Use of localised intracoronary beta radiation in treatment of in-stent restenosis: the INHIBIT randomised controlled trial. Lancet 2002, 359:551-557.
17. Teirstein PS, Massullo V, Jani S, et al.: Catheter-based radiotherapy to inhibit restenosis after coronary stenting. N Engl J Med 1997, 336:1697-1703.
18. Mehran R, Dangas G, Abizaid AS, et al.: Angiographic patterns of in-stent restenosis: classification and implications for long-term outcome. Circulation 1999, 100:1872-1878.
19. Ho KK: Predictors of angiographic restenosis after stenting: pooled analysis of 1197 patients with protocol-mandated angiographic follow-up from five randomized stent trials. Circulation 1998, (Suppl 1):362.
20. Brenner DJ, Miller RC, Hall EJ: The radiobiology of intravascular irradiation. Int J Radiat Oncol Biol Phys 1996, 36:805-810.
21. Hall EJ, Miller RC, Brenner DJ: Radiobiological principles in intravascular irradiation. Cardiovasc Radiat Med 1999, 1:42-47.
22. Rubin P, Soni A, Williams JP: The molecular and cellular biologic basis for the radiation treatment of benign proliferative diseases. Semin Radiat Oncol 1999, 9:203-214.
23. Williams JP, Rubin P, Soni A, et al.: Comparability of the external vs internal location of radiation in inhibiting neointimal hyperplasia. Cardiovasc Radiat Med 1999, 1:55-63.
24. Rees CR, Palmaz JC, Garcia O, et al.: Angioplasty and stenting of completely occluded iliac arteries. Radiology 1989, 172:953-959.
25. Rubin P, Williams J, Finkelstein J: Radiation inhibition versus induction of vascular restenosis. In Vascular Brachytherapy, edn 2. Edited by Waksman R. Futura Publishing Co.; 1999:103-126.
26. Jani S: Handbook of Dosimetry for Radiotherapy. Boca Raton: CRC Press; 1993.
27. Amols HI, Reinstein LE, Weinberger J: Dosimetry of a radioactive coronary balloon dilatation catheter for treatment of neointimal hyperplasia. Med Phys 1996, 23:1783-1788.
28. Amols HI, Zaider M, Weinberger J, et al.: Dosimetric considerations for catheter-based beta and gamma emitters in the therapy of neointimal hyperplasia in human coronary arteries. Int J Radiat Oncol Biol Phys 1996, 36:913-921.
29. Hall EJ: The physics and chemistry of radiation absorption. In Radiobiology for the Radiologist. Edited by Hall EJ. Philadelphia: JB Lippincott Co.; 1994:1-13.
30. King SB 3rd, Williams DO, Chougule P, et al.: Endovascular beta-radiation to reduce restenosis after coronary balloon angioplasty: results of the beta energy restenosis trial (BERT). Circulation 1998, 97:2025-2030.
31. Verin V, Urban P, Popowski Y, et al.: Feasibility of intracoronary beta-irradiation to reduce restenosis after balloon angioplasty: a clinical pilot study. Circulation 1997, 95:1138-1144.
32. Waksman R, Bhargava B, White L, et al.: Intracoronary beta-radiation therapy inhibits recurrence of in-stent restenosis. Circulation 2000, 101:1895-1898.
33. Raizner AE, Oesterle SN, Waksman R, et al.: Inhibition of restenosis with beta-emitting radiotherapy: report of the Proliferation Reduction with Vascular Energy Trial (PREVENT). Circulation 2000, 102:951-958.
34. Ajani AE, Waksman R, Sharma AK, et al.: Three-year follow-up after intracoronary gamma radiation therapy for in-stent restenosis: original WRIST. Washington Radiation for In-Stent Restenosis Trial. Cardiovasc Radiat Med 2001, 2:200-204.
35. Condado JA, Waksman R, Gurdiel O, et al.: Long-term angiographic and clinical outcome after percutaneous transluminal coronary angioplasty and intracoronary radiation therapy in humans. Circulation 1997, 96:727-732.
36. Kuntz RE, Baim DS: Prevention of coronary restenosis: the evolving evidence base for radiation therapy. Circulation 2000, 101:2130-2133.
37. Meerkin D, Tardif JC, Crocker IR, et al.: Effects of intracoronary beta-radiation therapy after coronary angioplasty: an intravascular ultrasound study. Circulation 1999, 99:1660-1665.
38. Bottcher HD, Schopohl B, Liermann D, et al.: Endovascular irradiation - A new method to avoid recurrent stenosis after stent implantation in peripheral arteries: technique and preliminary results. Int J Radiol Oncol Biol Phys 1994, 29:183-186.
39. Popma JJ, Suntharalingam M, Lansky AJ, et al.: Randomized trial of 90Sr/90Y beta-radiation versus placebo control for treatment of in-stent restenosis. Circulation 2002, 106:1090-1096.
40. Pokrajac B, Minar E, Kirisits C, Potter R: Present status of endovascular brachytherapy in peripheral arteries. Herz 2002, 27:56-61.
41. Sidawy AN, Weiswasser JM, Waksman R: Peripheral vascular brachytherapy. J Vasc Surg 2002, 35:1041-1047.
42. Waksman R, Laird JR, Jurkovitz CT, et al.: Intravascular radiation therapy after balloon angioplasty of narrowed femoropopliteal arteries to prevent restenosis: results of the PARIS feasibility clinical trial. J Vasc Interv Radiol 2001, 12:915-921.
43. Liermann D, Kirchner J, Bauernsachs R, et al.: Brachytherapy with iridium-192 HDR to prevent from restenosis in peripheral arteries: an update. Herz 1998, 23:394-400.
44. Liermann DD, Bauernsachs R, Schopohl B, et al.: Five year follow-up after brachytherapy for restenosis in peripheral arteries. Semin Interv Cardiol 1997, 2:133-137.
45. Use of gamma radiation for treatment of renal artery in-stent restenosis. Cardiovasc Radiat Med 2001, 2:197-198.
46. Aslam MS, Balasubramanian J, Greenspahn BR: Brachytherapy for renal artery in-stent restenosis. Catheter Cardiovasc Interv 2003, 58:151-154.
47. Chrysant GS, Goldstein JA, Casserly IP, et al.: Endovascular brachytherapy for treatment of bilateral renal artery in-stent restenosis. Catheter Cardiovasc Interv 2003, 59:251-254.
48. Jahraus CD, St Clair W, Gurley J, et al.: Endovascular brachytherapy for the treatment of renal artery in-stent restenosis using a beta-emitting source: a report of five patients. South Med J 2003, 96:1165-1168. A series of five cases of successfully administered renal brachytherapy, which used surrogate markers of target vessel failure.
49. Stoeteknuel-Friedli S, Do DD, von Briel C, et al.: Endovascular brachytherapy for prevention of recurrent renal in-stent restenosis. J Endovasc Ther 2002, 9:350-353.
50. Lufft V, Hoogestraat-Lufft L, Fels LM, et al.: Contrast media nephropathy: intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: a prospective randomized trial. Am J Kidney Dis 2002, 40:236-242.